U.S. markets closed
  • S&P 500

    3,831.39
    +6.06 (+0.16%)
     
  • Dow 30

    30,967.82
    -129.44 (-0.42%)
     
  • Nasdaq

    11,322.24
    +194.39 (+1.75%)
     
  • Russell 2000

    1,739.28
    +11.53 (+0.67%)
     
  • Crude Oil

    99.72
    -8.71 (-8.03%)
     
  • Gold

    1,766.50
    -35.00 (-1.94%)
     
  • Silver

    19.04
    -0.56 (-2.84%)
     
  • EUR/USD

    1.0269
    -0.0155 (-1.49%)
     
  • 10-Yr Bond

    2.8090
    -0.0800 (-2.77%)
     
  • GBP/USD

    1.1959
    -0.0145 (-1.20%)
     
  • USD/JPY

    135.7750
    +0.1150 (+0.08%)
     
  • BTC-USD

    20,380.51
    +559.93 (+2.83%)
     
  • CMC Crypto 200

    440.31
    +0.29 (+0.07%)
     
  • FTSE 100

    7,025.47
    -207.18 (-2.86%)
     
  • Nikkei 225

    26,423.47
    +269.66 (+1.03%)
     

Alkermes to Participate in the Jefferies Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DUBLIN, June 1, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 2:30 p.m. ET (7:30 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-jefferies-healthcare-conference-301558669.html

SOURCE Alkermes plc